{"nctId":"NCT00233324","briefTitle":"Surfactant Positive Airway Pressure and Pulse Oximetry Trial","startDateStruct":{"date":"2005-02"},"conditions":["Infant, Newborn, Diseases","Other Preterm Infants","Infant, Small for Gestational Age","Premature Birth","Bronchopulmonary Dysplasia","Retinopathy of Prematurity"],"count":1316,"armGroups":[{"label":"Surfactant and Low Oxygen","type":"EXPERIMENTAL","interventionNames":["Drug: Surfactant","Drug: Supplemental oxygen with target saturation of 85 to 89%"]},{"label":"Surfactant and High Oxygen","type":"EXPERIMENTAL","interventionNames":["Drug: Surfactant","Drug: Supplemental oxygen with target saturation of 91 to 95%"]},{"label":"CPAP and Low Oxygen","type":"EXPERIMENTAL","interventionNames":["Device: Continuous Positive Airway Pressure (CPAP)","Drug: Supplemental oxygen with target saturation of 85 to 89%"]},{"label":"CPAP and High Oxygen","type":"EXPERIMENTAL","interventionNames":["Device: Continuous Positive Airway Pressure (CPAP)","Drug: Supplemental oxygen with target saturation of 91 to 95%"]}],"interventions":[{"name":"Surfactant","otherNames":[]},{"name":"Continuous Positive Airway Pressure (CPAP)","otherNames":["CPAP"]},{"name":"Supplemental oxygen with target saturation of 85 to 89%","otherNames":["Low oxygen"]},{"name":"Supplemental oxygen with target saturation of 91 to 95%","otherNames":["High oxygen"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Infants with a minimal gestational age of 24 weeks 0 days to 27 completed weeks (up to 27 6/7ths) by best obstetrical estimate\n* Infants who will receive full resuscitation as necessary, i.e., no parental request or physician decision to forego resuscitation\n* Infants whose parents/legal guardians have provided consent for enrollment, or\n* Infants without known major congenital malformations\n\nExclusion Criteria:\n\n* Any infant transported to the center after delivery\n* Infants whose parents/legal guardians refuse consent\n* Infants born during a time when the research apparatus/study personnel are not available\n* Infants \\< 24 weeks 0 days or \\> 28 weeks 0 days, completed weeks of gestation","healthyVolunteers":false,"sex":"ALL","minimumAge":"24 Weeks","maximumAge":"27 Weeks","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Survival Without Bronchopulmonary Dysplasia (BPD)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"346","spread":null},{"groupId":"OG001","value":"320","spread":null}]}]}]},{"type":"PRIMARY","title":"Survival Without Severe Retinopathy of Prematurity (ROP) (Threshold Disease or the Need for Surgery)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"434","spread":null},{"groupId":"OG001","value":"418","spread":null}]}]}]},{"type":"SECONDARY","title":"Death or Neurodevelopmental Impairment","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null},{"groupId":"OG001","value":"183","spread":null},{"groupId":"OG002","value":"185","spread":null},{"groupId":"OG003","value":"171","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Mechanical Ventilation","description":"The length in days that an individual was on mechanical ventilation which includes high frequency and conventional ventilation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"13","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"11.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Survival Without Ventilation","description":"Surviving the first 7 days of life without any need for ventilation by day 7","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"161","spread":null},{"groupId":"OG001","value":"157","spread":null},{"groupId":"OG002","value":"190","spread":null},{"groupId":"OG003","value":"172","spread":null}]}]}]},{"type":"SECONDARY","title":"Received Surfactant Treatment","description":"Received any surfactant treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"159","spread":null},{"groupId":"OG001","value":"176","spread":null},{"groupId":"OG002","value":"42","spread":null},{"groupId":"OG003","value":"51","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Air Leaks","description":"Number of participants with air leaks including pnemothorax, pulmonary interstitial emphysema (PIE), and pneumopericardium.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"25","spread":null},{"groupId":"OG003","value":"20","spread":null}]}]}]},{"type":"SECONDARY","title":"Physiological Bronchopulmonary Dysplasia","description":"Infants who received support via ventilator or CPAP at 36 weeks PMA. Alternatively, infants who received low levels of supplemental oxygen (\\<30%) at 36 weeks PMA may have been eligible for a physiologic challenge in which there was an attempt to wean the infant to room air. Specifically, infants were eligible for the challenge if at 36 weeks PMA if they were receiving effective oxygen \\<27% and had majority saturation \\>90%, or they were receiving effective oxygen 27-30% and had majority saturation \\>96%, or they were receiving room air by nasal cannula. The challenge took place between 36 and 37 weeks PMA. Those who were not challenged because their level of support increased (support with CPAP or ventilation or increased oxygen) were considered to have BPD, as were those who failed the challenge.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null},{"groupId":"OG001","value":"117","spread":null},{"groupId":"OG002","value":"103","spread":null},{"groupId":"OG003","value":"120","spread":null}]}]}]},{"type":"SECONDARY","title":"Death","description":"Participants who died by their follow-up visit at 18-22 months.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"67","spread":null},{"groupId":"OG003","value":"51","spread":null}]}]}]},{"type":"SECONDARY","title":"Severe Intraventricular Hemorrhage (IVH)","description":"There are four grades of intraventricular hemorrhage: Grade I - echodensity/hemorrhage is confied to the germinal matrix. Grade II - echodensity/hemorrhage in the lateral ventricle(s) without distention. Grade III - echodensity/hemorrhage in the lateral ventricle(s) with distention. Grade IV - echodense lesion in the parenchyma. Severe IVH is defined as having IVH grades of III or IV.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"38","spread":null},{"groupId":"OG002","value":"49","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]}]},{"type":"SECONDARY","title":"Periventricular Leukomalacia (PVL)","description":"Increased echogenicity or cysts in periventricular region.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"16","spread":null},{"groupId":"OG002","value":"14","spread":null},{"groupId":"OG003","value":"14","spread":null}]}]}]},{"type":"SECONDARY","title":"Threshold Retinopathy of Prematurity (ROP) Requiring Surgery","description":"Diagnosis of retinopathy of prematurity which resulted in requiring surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"44","spread":null},{"groupId":"OG002","value":"17","spread":null},{"groupId":"OG003","value":"47","spread":null}]}]}]},{"type":"SECONDARY","title":"Endotracheal Intubation","description":"Insertion of a tube into the trachea to allow positive pressure ventilation for breathing.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"294","spread":null},{"groupId":"OG001","value":"315","spread":null},{"groupId":"OG002","value":"110","spread":null},{"groupId":"OG003","value":"117","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Oxygen Supplementation","description":"The length of time in days that a participant had oxygen supplementation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"60","spread":null},{"groupId":"OG002","value":"43","spread":null},{"groupId":"OG003","value":"59","spread":null}]}]}]},{"type":"SECONDARY","title":"Pulse Oximetry Values > 90%","description":"Percentage of time spent above 90% oxygen saturation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62","spread":null},{"groupId":"OG001","value":"76","spread":null},{"groupId":"OG002","value":"63","spread":null},{"groupId":"OG003","value":"77","spread":null}]}]}]},{"type":"SECONDARY","title":"Blindness in at Least One Eye","description":"Blindness in at least one eye by 18-22 months of life.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Received Postnatal Steroids","description":"Participant received any doses or courses of systemic steroids to prevent or treat bronchopulmonary dysplasia/chronic lung disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"41","spread":null},{"groupId":"OG002","value":"19","spread":null},{"groupId":"OG003","value":"28","spread":null}]}]}]},{"type":"SECONDARY","title":"Necrotizing Enterocolitis (NEC)","description":"Proven necrotizing enterocolitis (NEC) diagnosis using the Modified Bell's Staging Criteria for NEC.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"27","spread":null},{"groupId":"OG002","value":"40","spread":null},{"groupId":"OG003","value":"43","spread":null}]}]}]},{"type":"SECONDARY","title":"Cerebral Palsy","description":"Incidence of cerebral palsy.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"26","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Apgar Scores at 5 Minutes","description":"Apgar stands for \"Appearance, Pulse, Grimace, Activity, and Respiration\" and scores range from 1 (worst) to 10 (best) indicating a baby's condition 5 minutes after birth.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":204,"n":318},"commonTop":["Nasal Breakdown","Any other non-serious adverse event"]}}}